Community-acquired MRSA infection: an update.
Ragan
Patti
P
Epidemic Intelligence Service Fellow, Florida Department of Health, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002981:Clindamycin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D003428:Cross Infection / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D003937:Diagnosis, Differential; D004322:Drainage; D006801:Humans; D016106:Methicillin Resistance / Q000235:genetics*; D010353:Patient Education as Topic; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000235:genetics* / Q000302:isolation & purification; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination